Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)
Clinical trial NCT03456401 · TERMINATED
Trial details
- NCT number
- NCT03456401
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-11-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.